Skip to content
OpenCapital
Get started

Columbus McKinnon Corporation CMCO Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
UNITED STATES57%—

Other financials

Income statement

See full
Revenue$437.8M+77.3%
Gross profit$102.9M+28.9%
Operating income-$153.2M-3,206%
Net income-$238.2M-8,776%
EPS (diluted)-$7.70-8,456%

Balance sheet

See full
Cash & equivalents$96.6M+79.0%
Total debt$2.5B+352%
Total equity$1.4B+64.2%
Total assets$4.8B+175%

Cash flow

See full
Operating cash flow-$166.8M-568%
CapEx$7.5M+22.2%
Free cash flow-$174.3M-692%

Valuation

See full
Market cap$426.08M+3.3%
Enterprise value$2.83B+210%
P/S0.4×-0.1×

Profitability

See full
Gross margin30.1%-3.7pp
Operating margin-10%-15.7pp
Net margin-19.2%-19.8pp
FCF margin-15%—

Returns & leverage

See full
Return on equity-19.7%-20.3pp
Debt / equity1.7×+1.1×
Current ratio2×+0.2×